HOME >> MEDICINE >> NEWS
UPMC begins study of heart support device as a bridge to transplantation

PITTSBURGH, May 21 Doctors at UPMC have begun a study using an investigational cardiac device, the VentrAssist Left Ventricular Assist System (LVAD) to see whether it can be used safely and effectively in patients with end-stage heart failure.

The study hopes to enroll 30 patients overall for the multi-center feasibility trial throughout nine centers in the United States. Five patients at UPMC have received the device so far, and one has successfully received a heart transplant after waiting for nearly three months on the pump, two of which were spent at home on the device.

"The VentrAssist LVAD presents us with a third-generation mechanical solution for end-stage congestive heart failure that approaches the goal of minimal interference with a patient's life. In a subsequent study with this pump, we will focus on support for transplant candidates as well as permanent use for those who do not qualify for heart transplantation, hopefully demonstrating its advantages over previous technology," said Robert Kormos, M.D., co-director of heart transplantation, director of the artificial heart program, medical director of the McGowan Institute for Regenerative Medicine and professor of surgery, division of cardiothoracic surgery at the University of Pittsburgh School of Medicine.

The VentrAssist LVAD is a mechanical blood pump that is implanted in the body to assist the heart to pump blood around the body for people with end-stage heart failure. It is still an experimental investigational device that has been approved by the U.S. Food and Drug Administration only for the purposes of the study. The blood pump is made of titanium and weighs just over half a pound, compared to the 5 pounds of older pumps. The implanted blood pump is connected to the heart and the aorta by two tubes called cannulae. Blood is drawn directly from the left ventricle and returned to the aorta. The VentrAssist LVAD works in tandem with the natural heart and an ext
'"/>

Contact: Maureen McGaffin
McGaffinME@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
21-May-2007


Page: 1 2

Related medicine news :

1. Mercurys link to heart disease begins in blood vessel walls
2. Johns Hopkins begins aggressive screening for superbugs in children
3. Brain structure changes years before memory loss begins
4. Response to anti-HIV therapy improved if treatment begins six months after preventive regimen
5. Researchers find nicotine withdrawal begins quickly
6. NIAID begins clinical trial of West Nile virus vaccine
7. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. New study shows promise in reducing surgical risks associated with surgical bleeding
10. New study counts the economic cost of persistent pain in Australia
11. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2018)... ... 2018 , ... Pulse8’s Senior Director of Quality Products, Kari ... Shield of Kansas City, will present on “Boosting Stars Scores by Better Understanding ... the Fairmont Grand Del Mar in San Diego, California. , During this ...
(Date:12/5/2018)... ... December 05, 2018 , ... Children’s National ... the Precision Virtual Reality® medical visualization platform by Surgical Theater. This innovative, ... a never-before view of the anatomy and pathology of their patients’ complex ...
(Date:12/5/2018)... ... ... Since PermaLip™ implants are solid, patients do not have to worry ... a natural look. “I always double and triple check implant placement to ensure that ... Dr. Jessica Kulak, double board certified facial plastic surgeon at The Naderi Center for ...
(Date:12/5/2018)... , ... December 05, 2018 , ... You can now ... LTRMN. , LTRMN , is a powerhouse in the cannabis industry with several ... True Terpenes is an industry leading, award winning , botanical terpene company ...
(Date:11/29/2018)... ATLANTA (PRWEB) , ... November 29, 2018 , ... ... a new white paper today, “ Investing in the Future: Why Preventing Chronic ... and state-based interventions in chronic disease prevention, control, and health promotion. , ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for ... the launch of the Annatto-E™ product line, containing unique and natural vitamin E ... research, DFH’s new Annatto-E™ products are available in three dosages of 75mg (with ...
(Date:11/29/2018)... , ... November 29, 2018 , ... ... This unique product makes the company’s powerful electronic forms and eSignatures functionality accessible ... progress by leaps and bounds in the consumer space and it’s about time ...
(Date:11/28/2018)... (PRWEB) , ... November 28, 2018 , ... ... traveling to Israel’s Sheba Medical Center, Tel HaShomer this week to form a ... in his home country, the Democratic Republic of Congo. , On Thursday, ...
Breaking Medicine Technology:
Cached News: